Partnering deals and alliances with big pharma

152 views
113 views

Published on

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
152
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Partnering deals and alliances with big pharma

  1. 1. Partnering Deals and Alliances with Big Pharma The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depthinsight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing acompany’s dealmaking activity since 2005, allowing quick identification potential partners Partneringtherapy focus revealed Partnering activity since 2005 – number of deals per year Full listing ofpartnering deals Activity by deal type Activity by industry sector Activity by phase of development Activityby technology type Activity by therapeutic area Comprehensive access to over 3,000 partnering deals asrecorded at Current Agreement, together with contract documents if available Insight into the terms includedin a partnering agreement, together with real world clause examples, via contract documents Understand thekey deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of yourproposed deal terms for partner companies The Partnering Deals and Alliances with Big Pharma report provides the most comprehensive and in-depthinsight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. This premier report provides all the information you require to better understand big pharma partnering. One of the key aspects of partnering is finding those companies that are potential candidates for thedevelopment and commercialization of the next generation of therapies. A lot of resources are spent on findingpartners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver thecompany’s business development objectives. Over 300 charts allow quick understanding of each bigpharma companies dealmaking trends over the last four years. This report contains over 3,000 links to online copies of actual partnering deals as recorded at CurrentAgreement, together with contract documents if submitted to the Securities Exchange Commission bybigpharma and their partners. Contract documents provide the answers to numerous questions about a prospective partner’sflexibility on a wide range of important issues, many of which will have a significant impact on eachparty’s ability to derive value from the deal. The initial chapters of this report provide an orientation of bigpharma’s dealmaking and businessactivities. Chapter 1 provides an introduction to the report, whilst Chapter 2 lists the top 50 leading big pharma companies based on 2011 pharmaceutical revenues anddealmaking activity since 2005. Chapter 3 reviews the top deals of 2005-2013 according to reported deal size. Chapter 4 provides a summary on best practice on how to submit an opportunity to big pharma, to ensurebuilding of relationships and to obtain a prompt assessment and response from the business developmentfunction of the prospective partner. Chapter 5 lists forthcoming partnering events where valuable face to face meetings with bigpharma provide ahighly effective means of obtaining interest in novel opportunities. These events are where dealmaking getsPartnering Deals and Alliances with Big Pharma
  2. 2. initiated through numerous back to back meetings. The main body of the report is provided in chapter 6. In-depth profiles of every big pharma company provideeverything required to assess the suitability of a company as a prospective partner. Each profile includes acompany overview, partnering activity according to deal type, industry sector, phase of development, therapyarea and technology type. Each company profile provides a comprehensive listing of deal records available at Current Agreements, eachof which links direct to an online copy of the actual deal record plus contract document if filed with the SEC.Key benefits Partnering Deals and Alliances with Big Pharma provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing acompany’s dealmaking activity since 2005, allowing quick identification potential partners Partneringtherapy focus revealed Partnering activity since 2005 – number of deals per year Full listing ofpartnering deals Activity by deal type Activity by industry sector Activity by phase of development Activityby technology type Activity by therapeutic area Comprehensive access to over 3,000 partnering deals asrecorded at Current Agreement, together with contract documents if available Insight into the terms includedin a partnering agreement, together with real world clause examples, via contract documents Understand thekey deal terms the company has agreed in previous deals Undertake due diligence to assess suitability of yourproposed deal terms for partner companies Report scope Partnering Deals and Alliances with Big Pharma is intended to provide the reader with an in-depthunderstanding of the partnering activities of the leading fifty big pharma companies worldwide, enabling theeffective assessment and selection of partners of choice, based on the latest knowledge of a company’spartnering. Partnering Deals and Alliances with Big Pharma includes: Detailed company profiles for each of the top 50 big pharma companies, including: Partnering interests andindications Partnering activity since 2005 Partner companies since 2005 Partnering activity since 2005 by:Partner company Deal type Industry sector Stage of development Technology type Therapy area Over 300charts showing the dealmaking activity of each company since 2005 The tools to enable effective and efficientpreparation for partnering negotiation with big pharma 3,000 partnering deals as recorded at CurrentAgreement, together with contract documents if available The leading M&A and partnering deals by value2005-2012 The Partnering Deals and Alliances with Big Pharma report also provides comprehensive access to availablecontract documents for each of the fifty big pharma companies. Analyzing actual company agreements allows assessment of the following: What is actually granted by the agreement to the partner company? What exclusivity is granted? What is thepayment structure for the deal? How are sales and payments audited? What is the deal term? How are the keyterms of the agreement defined? How are IPRs handled and owned? Who is responsible forcommercialization? Who is responsible for development, supply, and manufacture? How is confidentiality andpublication managed? How are disputes to be resolved? Under what conditions can the deal be terminated?What happens when there is a change of ownership? What sublicensing and subscontracting provisions havebeen agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear todiffer from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon foragreement law?Partnering Deals and Alliances with Big Pharma
  3. 3. table Of Contentexecutive Summarychapter 1 – Introductionchapter 2 – Big Pharma Top 50 Dealmaking Activity2.1. Introduction2.2. Big Pharma Partnering Over The Years2.4. Big Pharma Partnering By Deal Type2.5. Big Pharma Partnering Industry Sector2.6. Big Pharma Partnering By Stage Of Development2.7. Big Pharma Partnering By Technology Type2.8. Big Pharma Partnering By Therapy Area2.9. Big Pharma M&a Over The Yearschapter 3 – Top Big Pharma Deals By Value3.1. Introduction3.2. Big Pharma Partnering3.3. Big Pharma M&achapter 4 – Submitting Opportunities To Big Pharma4.1. How To Submit An Opportunity4.2. Opportunity Submission Template4.3. Sending Emails4.4. Face To Face At Partnering Events4.5. Online Submission Formschapter 5 – Forthcoming Big Pharma Partnering Events5.1. Forthcoming Eventschapter 6 – Big Pharma Company Profiles6.1. Introduction6.2. Field Definitions6.3. Company ProfilesabbottPartnering Deals and Alliances with Big Pharma
  4. 4. actavis (formerly Watson Pharmaceuticals)actelionallerganamgenaspen Pharmacareastellasastrazenecabaxter Internationalbayerbiogen Idecboehringer Ingelheimbristol-myers Squibbcelgenecsldaiichi Sankyodainippon Sumitomoeisaieli Lillyendo Pharmaceuticalsforest Laboratoriesgaldermagilead Sciencesglaxosmithklinegrifolshospirajohnson & Johnson / Janssenkyowa Hakko Kirinlundbeckmenarinimerck & Comerck Kgaamitsubishi Tanabemylannovartisnovo Nordiskotsukapfizerpurdue Pharmarochesanofisanofi-aventisserviershionogiPartnering Deals and Alliances with Big Pharma
  5. 5. shiretakedatevaucbvaleant Pharmaceuticalswarner Chilcottchapter 7 – Resourcesappendicesappendix 1 – Deal Type Definitionsappendix 2 – Example Contract Documentabout Wildwood Venturescurrent Partneringcurrent Agreementscurrent Reportsrecent Titles From Currentpartneringorder Form – ReportsAbout Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.researchmoz.us/Partnering Deals and Alliances with Big Pharma

×